We are live on ! Find out more
BA

Bennicas & Associates Portfolio holdings

AUM $173M
1-Year Est. Return 1.55%
This Fund
S&P 500
This Quarter Est. Return
-11.91%
1 Year Est. Return
+1.55%
3 Year Est. Return
+40.28%
5 Year Est. Return
+86.07%
10 Year Est. Return
AUM
$113M
AUM Growth
-$25.1M
Cap. Flow
-$3.41M
Cap. Flow %
-3.01%
Top 10 Hldgs %
46.53%
Holding
85
New
Increased
5
Reduced
59
Closed
7

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$647K
2
MRK icon
Merck
MRK
+$541K
3
PG icon
Procter & Gamble
PG
+$411K
4
CPRT icon
Copart
CPRT
+$347K
5
ABBV icon
AbbVie
ABBV
+$326K

Sector Composition

Rank Sector Weight
1 Consumer Staples 23.75%
2 Healthcare 14.63%
3 Materials 12.99%
4 Technology 8.51%
5 Real Estate 5.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
1
Procter & Gamble
PG
$346B
$16.4M 14.47%
148,961
-3,425
-2% -$411K
SH icon
2
ProShares Short S&P500
SH
$916M
$6.62M 5.85%
59,863
+44,163
+281% +$4.46M
MSFT icon
3
Microsoft
MSFT
$2.9T
$5.6M 4.95%
35,507
-3,933
-10% -$647K
NEM icon
4
Newmont
NEM
$98.6B
$5.52M 4.87%
121,880
-2,776
-2% -$125K
CEF icon
5
Sprott Physical Gold and Silver Trust
CEF
$7.49B
$3.65M 3.22%
249,757
-10,000
-4% -$149K
ABBV icon
6
AbbVie
ABBV
$454B
$3.4M 3%
44,625
-3,825
-8% -$326K
FNV icon
7
Franco-Nevada
FNV
$41.4B
$3.08M 2.72%
31,000
+50
+0.2% +$5.43K
CLX icon
8
Clorox
CLX
$11.8B
$2.92M 2.58%
16,850
-800
-5% -$132K
MRK icon
9
Merck
MRK
$323B
$2.89M 2.55%
39,352
-6,881
-15% -$541K
PHYS icon
10
Sprott Physical Gold
PHYS
$14.7B
$2.6M 2.3%
198,427
-10,000
-5% -$127K
CSX icon
11
CSX Corp
CSX
$95.8B
$2.3M 2.03%
120,225
-8,700
-7% -$203K
WPM icon
12
Wheaton Precious Metals
WPM
$50.9B
$1.91M 1.68%
69,200
-3,500
-5% -$101K
HE icon
13
Hawaiian Electric Industries
HE
$2.28B
$1.87M 1.65%
43,500
-4,700
-10% -$217K
DIS icon
14
Walt Disney
DIS
$168B
$1.81M 1.6%
18,750
-875
-4% -$111K
MCHP icon
15
Microchip Technology
MCHP
$42.3B
$1.77M 1.56%
52,200
-2,366
-4% -$111K
T icon
16
AT&T
T
$167B
$1.74M 1.53%
78,836
-2,672
-3% -$73K
TGT icon
17
Target
TGT
$63.8B
$1.7M 1.51%
18,325
-1,338
-7% -$149K
PFE icon
18
Pfizer
PFE
$141B
$1.68M 1.49%
54,384
-2,266
-4% -$77.2K
TTE icon
19
TotalEnergies
TTE
$187B
$1.68M 1.48%
45,125
-1,000
-2% -$45K
CPRT icon
20
Copart
CPRT
$27.5B
$1.67M 1.47%
97,400
-15,600
-14% -$347K
LLY icon
21
Eli Lilly
LLY
$1.07T
$1.63M 1.44%
11,715
-1,628
-12% -$224K
PEP icon
22
PepsiCo
PEP
$190B
$1.62M 1.43%
13,458
-200
-1% -$27K
PAAS icon
23
Pan American Silver
PAAS
$18.6B
$1.52M 1.35%
106,254
-4,500
-4% -$93.5K
BMY icon
24
Bristol-Myers Squibb
BMY
$127B
$1.49M 1.32%
26,775
-1,900
-7% -$116K
GRX
25
Gabelli Healthcare & Wellness Trust
GRX
$142M
$1.49M 1.32%
172,200
-1,000
-0.6% -$10.6K

Similar funds

Bennicas & Associates's Q1 2020 Portfolio in Review

As of Q1 2020, Bennicas & Associates held 85 positions worth $113M, down 18% from $138M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Bennicas & Associates withdrew a net $3.41M in Q1 2020, closing 7 positions and reducing 59 holdings. Its most notable exit was Realty Income, an estimated $291K position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Materials.

Against the trend, Bennicas & Associates added an estimated $4.46M to ProShares Short S&P500.

  • Bennicas & Associates added most to ProShares Short S&P500 in Q1 2020, an estimated $4.46M increase.
  • Bennicas & Associates's biggest Q1 2020 reduction was Microsoft, cutting an estimated $647K.
  • Bennicas & Associates fully exited Realty Income in Q1 2020, selling an estimated $291K.
  • Bennicas & Associates's ten largest holdings make up 47% of its $113M portfolio in Q1 2020.
  • Bennicas & Associates opened 0 new positions and closed 7 in Q1 2020.
  • Bennicas & Associates's portfolio value fell 18% quarter-over-quarter to $113M.

Based on Bennicas & Associates's 13F filing for Q1 2020, filed 15 Apr 2020.